Silverback Therapeutics (SBTX) Competitors $13.97 +0.05 (+0.36%) As of 04/30/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrendsBuy This Stock SBTX vs. GMTX, NAMS, BLTE, JANX, SDGR, ARWR, CNTA, SUPN, GLPG, and IDYAShould you be buying Silverback Therapeutics stock or one of its competitors? The main competitors of Silverback Therapeutics include Gemini Therapeutics (GMTX), NewAmsterdam Pharma (NAMS), Belite Bio (BLTE), Janux Therapeutics (JANX), Schrödinger (SDGR), Arrowhead Pharmaceuticals (ARWR), Centessa Pharmaceuticals (CNTA), Supernus Pharmaceuticals (SUPN), Galapagos (GLPG), and IDEAYA Biosciences (IDYA). These companies are all part of the "pharmaceutical preparations" industry. Silverback Therapeutics vs. Gemini Therapeutics NewAmsterdam Pharma Belite Bio Janux Therapeutics Schrödinger Arrowhead Pharmaceuticals Centessa Pharmaceuticals Supernus Pharmaceuticals Galapagos IDEAYA Biosciences Silverback Therapeutics (NASDAQ:SBTX) and Gemini Therapeutics (NASDAQ:GMTX) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, valuation, dividends, institutional ownership, profitability, analyst recommendations and media sentiment. Is SBTX or GMTX more profitable? Silverback Therapeutics' return on equity of -29.62% beat Gemini Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Silverback TherapeuticsN/A -29.62% -28.20% Gemini Therapeutics N/A -38.78%-35.88% Which has more risk and volatility, SBTX or GMTX? Silverback Therapeutics has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500. Comparatively, Gemini Therapeutics has a beta of -0.12, suggesting that its stock price is 112% less volatile than the S&P 500. Does the MarketBeat Community favor SBTX or GMTX? Gemini Therapeutics received 1 more outperform votes than Silverback Therapeutics when rated by MarketBeat users. Likewise, 63.33% of users gave Gemini Therapeutics an outperform vote while only 56.25% of users gave Silverback Therapeutics an outperform vote. CompanyUnderperformOutperformSilverback TherapeuticsOutperform Votes1856.25% Underperform Votes1443.75% Gemini TherapeuticsOutperform Votes1963.33% Underperform Votes1136.67% Does the media refer more to SBTX or GMTX? In the previous week, Silverback Therapeutics' average media sentiment score of 0.00 equaled Gemini Therapeutics'average media sentiment score. Company Overall Sentiment Silverback Therapeutics Neutral Gemini Therapeutics Neutral Do institutionals and insiders hold more shares of SBTX or GMTX? 74.9% of Silverback Therapeutics shares are held by institutional investors. Comparatively, 75.4% of Gemini Therapeutics shares are held by institutional investors. 34.4% of Silverback Therapeutics shares are held by insiders. Comparatively, 12.9% of Gemini Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has preferable earnings & valuation, SBTX or GMTX? Gemini Therapeutics is trading at a lower price-to-earnings ratio than Silverback Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSilverback TherapeuticsN/AN/A-$89.48M-$2.42-5.77Gemini TherapeuticsN/AN/A-$71.87M-$1.00-49.42 SummarySilverback Therapeutics and Gemini Therapeutics tied by winning 5 of the 10 factors compared between the two stocks. Get Silverback Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SBTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SBTX vs. The Competition Export to ExcelMetricSilverback TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$503.73M$6.72B$5.49B$7.94BDividend YieldN/A3.05%5.11%4.23%P/E Ratio-5.777.3722.5818.55Price / SalesN/A242.94397.25103.00Price / CashN/A65.8538.1834.62Price / Book1.896.486.704.26Net Income-$89.48M$143.68M$3.23B$248.39M7 Day Performance-2.85%1.79%1.26%1.27%1 Month Performance11.05%6.68%3.75%3.85%1 Year Performance49.73%-2.73%15.78%5.23% Silverback Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SBTXSilverback TherapeuticsN/A$13.97+0.4%N/A+60.0%$503.73MN/A-5.7783High Trading VolumeGMTXGemini TherapeuticsN/A$45.42-1.6%N/A+66.7%$1.97BN/A-45.4230NAMSNewAmsterdam Pharma3.1636 of 5 stars$17.83+1.8%$43.33+143.0%-12.3%$1.96B$45.56M-6.864Positive NewsBLTEBelite Bio2.9736 of 5 stars$60.18+3.3%$96.67+60.6%+51.4%$1.92BN/A-54.2210News CoveragePositive NewsJANXJanux Therapeutics3.0291 of 5 stars$32.23+3.8%$95.25+195.5%-41.8%$1.90B$10.59M-27.5530Upcoming EarningsNews CoveragePositive NewsGap DownSDGRSchrödinger2.273 of 5 stars$25.75-2.6%$33.00+28.2%+5.1%$1.88B$207.54M-11.00790Upcoming EarningsARWRArrowhead Pharmaceuticals3.6149 of 5 stars$13.52+2.0%$41.44+206.5%-38.6%$1.86B$2.50M-2.62400News CoveragePositive NewsCNTACentessa Pharmaceuticals2.5659 of 5 stars$13.75-0.3%$27.71+101.6%+49.7%$1.83B$6.85M-8.99200News CoveragePositive NewsSUPNSupernus Pharmaceuticals3.0191 of 5 stars$32.25+0.1%$36.00+11.6%+7.9%$1.80B$661.82M30.14580Upcoming EarningsGap DownGLPGGalapagos0.617 of 5 stars$26.87+0.0%$25.33-5.7%-5.4%$1.77B$288.19M0.001,310Options VolumeHigh Trading VolumeIDYAIDEAYA Biosciences3.7128 of 5 stars$19.75+3.9%$53.58+171.3%-50.5%$1.73B$7M-5.9880Upcoming EarningsPositive NewsHigh Trading Volume Related Companies and Tools Related Companies GMTX Alternatives NAMS Alternatives BLTE Alternatives JANX Alternatives SDGR Alternatives ARWR Alternatives CNTA Alternatives SUPN Alternatives GLPG Alternatives IDYA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SBTX) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silverback Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Silverback Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SBTX Stock Free SBTX Stock Alerts